# Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP

> **NCT03978559** · PHASE4 · UNKNOWN · sponsor: **Bin Du** · enrollment: 122 (estimated)

## Conditions studied

- Pneumocystis Pneumonia

## Interventions

- **DRUG:** caspofungin
- **DRUG:** TMP/SMZ(trimethoprim/sulfisoxazole)
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT03978559
- **Lead sponsor:** Bin Du
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-14
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-07-08
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03978559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03978559, "Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03978559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*